artemether; lumefantrine
artemether; lumefantrine: sourced relationships with 1 company · 2 clinical trials tracked · 1 FDA decision.
artemether; lumefantrine evidence translation
What we can confirm
1 FDA record · 2 tracked trials
What it means
What to watch
Prepared research question
How could artemether; lumefantrine → NVS affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Novartis AG (NVS) Reported 2009-04-07 · Current development: unknownSource Uncomplicated Plasmodium Falciparum Malaria; Severe Malaria | Phase 4 |
Clinical Trial Registry Records (2)
An Adaptive, Randomized, Active-controlled, Open-label, Sequential Cohort, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Intravenous Cipargamin (KAE609) in Adult and Pediatric Participants With Severe Plasmodium Falciparum Malaria (KARISMA - KAE609's Role In Severe Malaria)
Primary endpoint: Percentage of Participants Achieving at Least 90% Reduction in Plasmodium Falciparum (P. Falciparum) at 12 Hours
A Phase 2 Interventional, Multicenter, Randomized, Open-label Study in Three Age-descending Cohorts to Evaluate Efficacy, Safety and Tolerability of KAF156 and Lumefantrine-SDF Combination in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in a Pediatric Population
Primary endpoint: Polymerase Chain Reaction (PCR)-Corrected Adequate Clinical and Parasitological Response (ACPR) - Cohorts 1 and 2 Pooled
FDA Decisions1 records
Frequently asked questions
Which companies have sourced relationships with artemether; lumefantrine?
artemether; lumefantrine has dated SEC/FDA relationship records for Novartis AG.
How many clinical trials involve artemether; lumefantrine?
BioSniper tracks 2 clinical trials involving artemether; lumefantrine.
What is artemether; lumefantrine's latest FDA decision?
The most recent tracked FDA decision for artemether; lumefantrine is Approval, dated April 7, 2009.